All Resources

Navigating Real-World Evidence in Ophthalmology

Communicating with patients requiring anti-VEGF intravitreal injections and their families during the COVID-19 pandemic: an update

Anti-VEGF Intravitreal Injections in the Era of COVID-19: Responding to Different Levels of Epidemic Pressure

Anti-VEGF Intravitreal Injections in the Era of COVID-19: Responding to Different Levels of Epidemic Pressure

Anti-VEGF Intravitreal Injections in the Era of COVID-19: Responding to Different Levels of Epidemic Pressure

Management of Retinal Pigment Epithelium Tear During Anti-VEGF Therapy

Monitoring of the Fellow Eye in nAMD

The Role of OCT-A in Retinal Disease Management

Fundamental Principles of an Effective Diabetic Retinopathy Screening Program

Monitoring of the Fellow Eye in Neovascular Age-Related Macular Degeneration

COVID-19 Patient Information Video

Communicating with patients with nAMD and their families during the COVID-19 pandemic

Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic

Real-World Evidence in Ophthalmic Clinical Practice: Conducting an Audit

Evolving Clinical Practice: Insights Gained from Real-World Evidence

Current concepts and modalities for monitoring the fellow eye in neovascular age-related macular degeneration

Management of Retinal Pigment Epithelium Tear During Anti-VEGF Therapy

Suspending treatment of neovascular age-related macular degeneration in cases of futility

Suspending Treatment of Neovascular Age-Related Macular Degeneration in Cases of Futility

Use of Bilateral Anti-VEGF Injections

Coordinated Care in Diabetic Eye Disease Management

Management of Subfoveal Hemorrhage

Use of Topical Antibiotics with Intravitreal Injections

A Patient With Type 1 Diabetes, Visual Acuity Loss, and Retinal Thickening

The Role of OCT-A in Retinal Disease Management

Topical Antibiotics and Intravitreal Injections

Fundamental Principles of an Anti-VEGF Treatment Regimen: Optimal Application of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy of Macular Diseases

The role of OCT-A in retinal disease management

Association between diabetic eye disease and other complications of diabetes: Implications for care. A systematic review

Futility of treatment viewpoint video - David Wong

Bilateral VEGF viewpoint video - Ian Pearce

Vision Academy EASD symposium 2017 - Diabetic eye disease - A treatable complication of diabetes

Vision Academy COPHy Europe symposium 2018_Suspending treatment debates

Topical antibiotics viewpoint video - Alex Hunyor

Fundamental principles of anti VEGF viewpoint video - Paolo Lanzetta

Vision Academy COPHy Europe symposium 2017 Bilateral anti-VEGF debates

Vision Academy COPHy Europe symposium 2018 Optimal anti-VEGF debates

Vision Academy COPHy Europe symposium 2017 Topical antibiotics debates

Vision Academy COPHy AA symposium 2018 Topical antibiotics debates

Vision Academy COPHy AA symposium 2018 Optimal VEGF debates

Vision Academy EASD symposium 2017 - The association between DR and other complications of diabetes

Additional Measures of Visual Function Beyond Acuity

Use of Topical Antibiotics with Intravitreal Injections

Fundamental Principles of an Anti-VEGF Treatment Regimen

Bilateral Anti-VEGF Treatment

Management of Subfoveal Hemorrhage